3rd Quarter - Report

CAPITOL COUNSEL LLC for ASTRAZENECA PHARMACEUTICALS, LP

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

HR 4679 - Stop Corporate Inversions Act of 2014, S. 2360 - Stop Corporate Inversions Act of 2014 (in the context of corporate acquisition activity).

Foreign entity interest: Foreign parent company affected by policies that affect AstraZeneca Pharmaceuticals, LP.

LobbyistCovered position, as disclosed
AARON COHEN —
SHANNON FINLEY —
JOSH KARDON —
JOHN J O'NEILL —
JOHN D RAFFAELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2360 (113th), H.R. 4679 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.